Performance against the 62 day cancer target increased with 59.6% of patients starting their first definitive treatment in the month within the target time.
Roedd y perfformiad ar gyfer y targed canser 62 diwrnod wedi cynyddu gyda 59.6% o gleifion yn dechrau ar eu triniaeth ddiffiniol gyntaf yn ystod y mis o fewn yr amser targed.